Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials

Podcast: Diabetes Insights - Breakthroughs and Innovators · EASD - European Association for the Study of Diabetes

Opublikowano: 2026-03-13

Exploring disease-modifying therapies and precision medicine in type 1 diabetes Watch the full video on YouTube to explore the latest findings from two major clinical trials investigating disease-modifying therapies for type 1 diabetes. In this episode, Prof. Chantal Mathieu (KU Leuven, endocrinologist and leading researcher in type 1 diabetes) and Prof. Francesco Dotta (University of Siena, expert in type 1 diabetes pathophysiology and clinical trials) discuss the MELD-ATG and VERA-T1D trials conducted through the European INNODIA consortium. Topics include: The goals of the INNODIA consortium and its role in advancing type 1 diabetes research The VERA-T1D trial...